Edition:
India

Luye Pharma Group Says Unit To Acquire 2 Biological Antibody Drugs Under R&D For RMB500 Mln


Friday, 21 Dec 2018 

Dec 21 (Reuters) - Luye Pharma Group Ltd <2186.HK>::UNIT TO ACQUIRE 2 BIOLOGICAL ANTIBODY DRUGS UNDER RESEARCH AND DEVELOPMENT FOR RMB500 MILLION FROM SHANDONG BOAN BIOLOGICAL TECHNOLOGY. 

Company Quote

5.56
-0.14 -2.46%
9:14am IST